findmyKOL

Sarkis Kiramijyan, MD

Basic profile

White Memorial Medical Center

ORCIDNone on fileNPI
RegionGlendale, CA · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Sarkis Kiramijyan is a Cardiology physician affiliated with White Memorial Medical Center. OpenAlex indexes 93 publications with 908 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
93publications

Distinct works indexed by OpenAlex.

908citations

Total citations across indexed works.

19h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
51companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1560 E Chevy Chase Dr Ste 400
Glendale, CA 912064197

Telephone

951-278-5590

Provider last certified this registry record 21 Nov 2023.

View the NPPES registry record

Industry payments

51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.8%
    Beta blocker15.2%
    Metoprolol Succinate67%Carvedilol22%Sotalol3%Labetalol Hcl3%Atenolol2%Metoprolol Tartrate2%Bisoprolol Fumarate1%Nebivolol Hcl1%
    Part D<11 patients
    Other lipid modifying agents11.5%
    Vascepa57%Icosapent Ethyl43%
    Part D197 patients

    + 22 more classes in this area

  • Blood & clotting

    9.7%
    P2Y12 inhibitor5%
    Clopidogrel63%Brilinta30%Prasugrel Hcl8%
    Part D<11 patients
    Factor Xa inhibitor4.3%
    Eliquis84%Xarelto16%
    Part D90 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    5.8%
    SGLT2 inhibitor2.5%
    Jardiance66%Farxiga25%Dapagliflozin9%
    Part D54 patients
    Nicotinic Acid1.3%
    Niacin Er100%
    Part D34 patients

    + 4 more classes in this area

Where care is delivered (Part B)45.5% facility · 54.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”